Cost-Effectiveness Analysis of Formoterol Versus Salmeterol in Patients with Asthma

被引：0
作者：
Maureen P. M. H. Rutten-van Mölken
Eddy K. A. van Doorslaer
M. Denise Till
机构：
[1] Erasmus University Rotterdam,Institute for Medical Technology Assessment
[2] Novartis,undefined
来源：
PharmacoEconomics | 1998年 / 14卷
关键词：
Adis International Limited; Salbutamol; Salmeterol; Formoterol; Emergency Room Visit;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective: The aim of this study was to determine the relative economic consequences of treating asthmatics with twice daily dry powder formoterol 12mg as compared with salmeterol 50mg from a societal perspective.
引用
收藏
页码：671 / 684
页数：13
相关论文
共 66 条
  • [1] Lofdahl CG(1991)Long-acting b2-adrenoceptor agonists: a new perspective in the treatment of asthma Eur Respir J 4 218-26
  • [2] Chung KF L(1990)Long-term efficacy of formoterol compared to salbutamol Lung 168 S76-92
  • [3] Hekking PR(1991)A three-months comparison of twice daily inhaled formoterol versus four times daily albuterol in the management of stable asthma Am Rev Respir Dis 144 622-5
  • [4] Maesen F(1992)A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma N Engl J Med 327 1420-5
  • [5] Greefhorst A(1993)Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment BMJ 306 1304-7
  • [6] Kesten S(1995)Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life Eur Respir J 8 888-98
  • [7] Chapman KR(1995)Validation of an asthma quality of life diary in a clinical trial Thorax 50 724-30
  • [8] Broder I(1995)Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol Am J Respir Crit Care Med 151 66-70
  • [9] Pearlman DS(1994)Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid Lancet 344 219-24
  • [10] Chervinsky P(1996)Salmeterol and formoterol in patients with moderately severe asthma: onset and duration of action Am J Respir Crit Care Med 153 1481-8
1234567